{'fraction_non_alphanumeric': 0.0234375, 'fraction_numerical': 0.0, 'mean_word_length': 5.370165745856354, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Participation in HIV vaccine trials: listening to participant & community concerns.

The terrible truth about the HIV/AIDS pandemic is that it affects men, women and children indiscriminately. In India, almost half of all infections are among women, a population with few risk factors beyond those that men place them at . Additionally, as the number of orphaned children from AIDS increases, we need to realize that disease risks arise from one’s social positioning, making vulnerable groups unable to negotiate adequate education, security from exploitation, and safe sex practices. The search for a scientific intervention capable of slowing the pandemic resembles a quest for a holy grail, a search almost unattainable, but with the potential to stop suffering of a Himalayan proportion. Effective prevention interventions exist, focused on peer-based condom use and behaviour change for vulnerable groups. These strategies need to be complemented by additional prevention tools. Scientists are placing their efforts with prevention strategies such as circumcision, pre-exposure prophylaxis and microbicides; but the most elusive is an HIV vaccine.